[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342873-105":59,"doc-detail-342873-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","hallmarks-of-cancer-resistance-review","Hallmarks of cancer resistance - Review","","This review explores the hallmarks of cancer resistance, focusing on drug efflux mediated by ABC transporters, metabolic reprogramming such as the Warburg effect, and the dynamic relationship between cancer cells and mitochondria. It examines how cancer stem cells contribute to treatment resistance and how regulatory non-coding RNAs, including lncRNAs, miRNAs, and circRNAs, shape resistance. The discussion highlights future directions in immunotherapy, strategies to counter adaptive resistance, AI-enabled predictive modeling, and biomarker-driven personalized treatment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hallmarks-of-cancer-resistance-review/342873/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hallmarks-of-cancer-resistance-review/342873.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What are the key hallmarks of cancer resistance discussed in this review?","Question",{"text":112,"@type":113},"The review covers drug efflux via ABC transporters, metabolic reprogramming including the Warburg effect, and the interplay between cancer cells and mitochondria.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do cancer stem cells and non-coding RNAs relate to treatment resistance?",{"text":117,"@type":113},"Cancer stem cells are highlighted as contributors to resistance, while regulatory non-coding RNAs (lncRNAs, miRNAs, circRNAs) are described as influencing resistance pathways.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is understanding cancer resistance important for improving patient outcomes?",{"text":121,"@type":113},"It helps identify targets and strategies to mitigate or overcome resistance, supporting more durable responses and enabling personalized treatment decisions.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342873,1790167580,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","iScience  \nll  \nOPEN ACCESS  \nReview  \nHallmarks of cancer resistance  \nMuhammad Tufail, 1 Jia-Ju Hu, 1 Jie Liang, 1 Cai-Yun He,1 Wen-Dong Wan,1 Yu-Qi Huang,1 Can-Hua Jiang, 1,2,3,4 Hong Wu,5 and Ning Li1,2,3,4,*  \nSUMMARY  \nThis review explores the hallmarks of cancer resistance, including drug efﬂux mediated by ATP-binding cassette (ABC) transporters, metabolic reprogramming characterized by the Warburg effect, and the dynamic interplay between cancer cells and mitochondria. The role of cancer stem cells (CSCs) in treatment resistance and the regulatory inﬂuence of non-coding RNAs, such as long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and circular RNAs (circRNAs), are studied. The chapter emphasizes future directions, encompassing advancements in immunotherapy, strategies to counter adaptive resistance, integration of artiﬁcial intelligence for predictive modeling, and the identiﬁcation of biomarkers for personalized treatment. The comprehensive exploration of these hallmarks provides a foundation for innovative therapeutic approaches, aiming to navigate the complex landscape of cancer resistance and enhance patient outcomes.  \nINTRODUCTION  \nDespite signiﬁcant advances in our understanding of cancer biology and the development of novel therapeutic approaches, the phenomenon of cancer resistance remains a persistent challenge. This resistance is characterized by the remarkable ability of cancer cells to evade the cytotoxic effects of treatments, thereby compromising the effectiveness of therapies and, ultimately, endangering the lives of countless individuals.1 In our pursuit of effective cancer management, it is imperative to unravel the intricate web of mechanisms underlying the hallmarks of cancer resistance.  \nCancer resistance represents a multifaceted spectrum of mechanisms that enable malignant cells to withstand even the most potent therapeutic strategies. From the early days of chemotherapy to the emergence of targeted therapies and immunotherapies, cancer cells have displayed an exceptional capacity to adapt, evolve, and persist.1 This resistance can manifest in various forms, including inherent resistance, acquired resistance, and adaptive resistance, further complicating the landscape of cancer treatment.  \nInherent resistance is often rooted in the genetic and epigenetic characteristics of cancer cells, predisposing certain tumors to be refractory to conventional treatments.2 Acquired resistance, on the other hand, emerges in response to the selective pressure exerted by therapeutic interventions, resulting in the emergence of treatment-resistant subpopulations within the tumor.3 Additionally, adaptive resistance occurs when cancer cells dynamically alter their behavior and signaling pathways in response to treatment, rendering once-potent therapies ineffective.4  \nThe challenges posed by cancer resistance extend beyond the realm of chemotherapy and encompass the evolving ﬁeld of targeted therapies and immunotherapies. Even therapies that initially elicit remarkable responses frequently encounter a formidable adversary in the form of resistance.5 The ongoing evolution of resistance mechanisms necessitates a holistic understanding of cancer biology that transcends reductionist views and embraces the complex, dynamic, and adaptable nature of cancer.  \nThe signiﬁcance of comprehending cancer resistance cannot be overstated. It holds the key to improving patient outcomes, enhancing the durability of treatment responses, and ultimately advancing the ﬁeld of oncology.6 Without a profound understanding of resistance mechanisms, we are left with an incomplete picture of cancer’s resilience and a limited array of treatment options.7  \nBy gaining insights into the hallmarks of cancer resistance, we can not only identify novel targets for therapeutic intervention but also develop strategies to mitigate or overcome resistance.8 This knowledge empowers clinicians to tailor treatment regimens to individual patients, ult","cbCaibgpIYV9R52S","https://ap.wps.com/l/cbCaibgpIYV9R52S","pdf",7110102,38,"English","# Summary\n# Introduction\n## Mechanisms of cancer resistance: inherent, acquired, adaptive\n## Therapeutic implications for targeted therapies and immunotherapies\n## Future perspectives: targets, personalized treatment, and combination strategies\n# Figure 1. Genomic instability in cancer biology and therapy resistance","[{\"question\":\"What are the key hallmarks of cancer resistance discussed in this review?\",\"answer\":\"The review covers drug efflux via ABC transporters, metabolic reprogramming including the Warburg effect, and the interplay between cancer cells and mitochondria.\"},{\"question\":\"How do cancer stem cells and non-coding RNAs relate to treatment resistance?\",\"answer\":\"Cancer stem cells are highlighted as contributors to resistance, while regulatory non-coding RNAs (lncRNAs, miRNAs, circRNAs) are described as influencing resistance pathways.\"},{\"question\":\"Why is understanding cancer resistance important for improving patient outcomes?\",\"answer\":\"It helps identify targets and strategies to mitigate or overcome resistance, supporting more durable responses and enabling personalized treatment decisions.\"}]","Hallmarks of cancer resistance - Review | PDF",1790048532,96,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/712e113592aae61e9fde17337bd46596.webp",983,1276,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1abaf2d8a611a98137d3fca7ab300cc2.webp",982,1275,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8023faa703ee7d084f47ff12099a2d3e.webp",981,1273,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/efba047bcd177192221002812af25c53.webp",980,1272]